Associate Director
Blueprint Medicines Corporation
Anitha Suram is a dedicated clinical pharmacologist currently serving as Associate Director at Blueprint Medicines. With a strong foundation as a trained cell and molecular biologist holding a PhD in Biochemistry, her journey in pursuit of knowledge led her to the United States. Here, she delved into postdoctoral research, specializing in cancer biology and the pivotal role of telomeres.
Throughout her career, Anitha’s work with pre-clinical animal models ignited a profound interest in pharmacokinetics and drug dynamics. Seeking to fortify her expertise, she pursued a Masters in Pharmacometrics at the University of Maryland, a pivotal step that expander her horizons in clinical pharmacology.
An advocate for Model-Informed Drug Development (MIDD), Anitha is passionate about utilizing these approaches to comprehensively characterize drug-disease interactions and elucidate the intricate relationships between pharmacokinetics and pharmacodynamics (PK/PD) across the entire drug development cycle.